These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 15827571)
21. Loss of TRPV1-expressing sensory neurons reduces spinal mu opioid receptors but paradoxically potentiates opioid analgesia. Chen SR; Pan HL J Neurophysiol; 2006 May; 95(5):3086-96. PubMed ID: 16467418 [TBL] [Abstract][Full Text] [Related]
22. Delta opioid receptor enhancement of mu opioid receptor-induced antinociception in spinal cord. He L; Lee NM J Pharmacol Exp Ther; 1998 Jun; 285(3):1181-6. PubMed ID: 9618421 [TBL] [Abstract][Full Text] [Related]
23. Activation of mu-opioid receptors transfers control of Galpha subunits to the regulator of G-protein signaling RGS9-2: role in receptor desensitization. Garzón J; Rodríguez-Muñoz M; López-Fando A; Sánchez-Blázquez P J Biol Chem; 2005 Mar; 280(10):8951-60. PubMed ID: 15632124 [TBL] [Abstract][Full Text] [Related]
24. Endogenous regulator of g protein signaling proteins reduce {mu}-opioid receptor desensitization and down-regulation and adenylyl cyclase tolerance in C6 cells. Clark MJ; Traynor JR J Pharmacol Exp Ther; 2005 Feb; 312(2):809-15. PubMed ID: 15383633 [TBL] [Abstract][Full Text] [Related]
25. Gx/z is regulated by mu but not delta opioid receptors in the stimulation of the low Km GTPase activity in mouse periaqueductal grey matter. Garzón J; Martínez-Peña Y; Sanchez-Blázquez P Eur J Neurosci; 1997 Jun; 9(6):1194-200. PubMed ID: 9215703 [TBL] [Abstract][Full Text] [Related]
26. Suppression of RGSz1 function optimizes the actions of opioid analgesics by mechanisms that involve the Wnt/β-catenin pathway. Gaspari S; Purushothaman I; Cogliani V; Sakloth F; Neve RL; Howland D; Ring RH; Ross EM; Shen L; Zachariou V Proc Natl Acad Sci U S A; 2018 Feb; 115(9):E2085-E2094. PubMed ID: 29440403 [TBL] [Abstract][Full Text] [Related]
27. Activation of Mas oncogene-related gene (Mrg) C receptors enhances morphine-induced analgesia through modulation of coupling of μ-opioid receptor to Gi-protein in rat spinal dorsal horn. Wang D; Chen T; Zhou X; Couture R; Hong Y Neuroscience; 2013 Dec; 253():455-64. PubMed ID: 24042038 [TBL] [Abstract][Full Text] [Related]
28. Decreased mu-opioid receptor signalling and a reduction in calcium current density in sensory neurons from chronically morphine-treated mice. Johnson EE; Chieng B; Napier I; Connor M Br J Pharmacol; 2006 Aug; 148(7):947-55. PubMed ID: 16783402 [TBL] [Abstract][Full Text] [Related]
29. Opioid peptide receptor studies. 17. Attenuation of chronic morphine effects after antisense oligodeoxynucleotide knock-down of RGS9 protein in cells expressing the cloned Mu opioid receptor. Xu H; Wang X; Wang J; Rothman RB Synapse; 2004 Jun; 52(3):209-17. PubMed ID: 15065220 [TBL] [Abstract][Full Text] [Related]
30. Suppression of the morphine-induced rewarding effect and G-protein activation in the lower midbrain following nerve injury in the mouse: involvement of G-protein-coupled receptor kinase 2. Ozaki S; Narita M; Narita M; Iino M; Miyoshi K; Suzuki T Neuroscience; 2003; 116(1):89-97. PubMed ID: 12535942 [TBL] [Abstract][Full Text] [Related]
31. Chronic treatment with the opioid antagonist naltrexone favours the coupling of spinal cord μ-opioid receptors to Gαz protein subunits. Valdizán EM; Díaz A; Pilar-Cuéllar F; Lantero A; Mostany R; Villar AV; Laorden ML; Hurlé MA Neuropharmacology; 2012 Feb; 62(2):757-64. PubMed ID: 21903117 [TBL] [Abstract][Full Text] [Related]
32. Supersensitivity to mu-opioid receptor-mediated inhibition of the adenylyl cyclase pathway involves pertussis toxin-resistant Galpha protein subunits. Mostany R; Díaz A; Valdizán EM; Rodríguez-Muñoz M; Garzón J; Hurlé MA Neuropharmacology; 2008 May; 54(6):989-97. PubMed ID: 18384820 [TBL] [Abstract][Full Text] [Related]
33. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence. Wells JL; Bartlett JL; Ananthan S; Bilsky EJ J Pharmacol Exp Ther; 2001 May; 297(2):597-605. PubMed ID: 11303048 [TBL] [Abstract][Full Text] [Related]
34. Region-dependent attenuation of mu opioid receptor-mediated G-protein activation in mouse CNS as a function of morphine tolerance. Sim-Selley LJ; Scoggins KL; Cassidy MP; Smith LA; Dewey WL; Smith FL; Selley DE Br J Pharmacol; 2007 Aug; 151(8):1324-33. PubMed ID: 17572699 [TBL] [Abstract][Full Text] [Related]
35. Endogenous regulator of G protein signaling proteins suppress Galphao-dependent, mu-opioid agonist-mediated adenylyl cyclase supersensitization. Clark MJ; Neubig RR; Traynor JR J Pharmacol Exp Ther; 2004 Jul; 310(1):215-22. PubMed ID: 15014136 [TBL] [Abstract][Full Text] [Related]
36. Opioid tolerance in periaqueductal gray neurons isolated from mice chronically treated with morphine. Bagley EE; Chieng BC; Christie MJ; Connor M Br J Pharmacol; 2005 Sep; 146(1):68-76. PubMed ID: 15980868 [TBL] [Abstract][Full Text] [Related]
37. RGS17/RGSZ2 and the RZ/A family of regulators of G-protein signaling. Nunn C; Mao H; Chidiac P; Albert PR Semin Cell Dev Biol; 2006 Jun; 17(3):390-9. PubMed ID: 16765607 [TBL] [Abstract][Full Text] [Related]
38. Morphine activates Arc expression in the mouse striatum and in mouse neuroblastoma Neuro2A MOR1A cells expressing mu-opioid receptors. Ziółkowska B; Urbański MJ; Wawrzczak-Bargieła A; Bilecki W; Przewłocki R J Neurosci Res; 2005 Nov; 82(4):563-70. PubMed ID: 16211563 [TBL] [Abstract][Full Text] [Related]
39. [(35)S]GTPγS binding and opioid tolerance and efficacy in mouse spinal cord. Madia PA; Navani DM; Yoburn BC Pharmacol Biochem Behav; 2012 Mar; 101(1):155-65. PubMed ID: 22108651 [TBL] [Abstract][Full Text] [Related]
40. delta Opioid receptor subtypes activate inositol-signaling pathways in the production of antinociception. Sánchez-Blázquez P; Garzón J J Pharmacol Exp Ther; 1998 May; 285(2):820-7. PubMed ID: 9580632 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]